The effects of biocompatible compared with standard peritoneal dialysis solutions on peritonitis microbiology, treatment, and outcomes: The balANZ trial

D.W. Johnson, F.G. Brown, M. Clarke, Neil Boudville, T.J. Elias, M.W.Y. Foo, B. Jones, H. Kulkarni, R. Langham, D. Ranganathan, J. Schollum, M.G. Suranyi, S.H. Tan, D. Voss

    Research output: Contribution to journalArticle

    50 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)497-506
    JournalPeritoneal Dialysis International
    Volume32
    DOIs
    Publication statusPublished - 2012

    Cite this

    Johnson, D. W., Brown, F. G., Clarke, M., Boudville, N., Elias, T. J., Foo, M. W. Y., Jones, B., Kulkarni, H., Langham, R., Ranganathan, D., Schollum, J., Suranyi, M. G., Tan, S. H., & Voss, D. (2012). The effects of biocompatible compared with standard peritoneal dialysis solutions on peritonitis microbiology, treatment, and outcomes: The balANZ trial. Peritoneal Dialysis International, 32, 497-506. https://doi.org/10.3747/pdi.2012.00052